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ROLE	OF	miRNA	FROM	MELANOMA	CELL-DERIVED	EXOSOMES	IN	TUMOR	
IMMUNE	ESCAPE	
	
Virginie	Vignard,	Nathalie	Labarrière	and	Delphine	Fradin	
Team	3	–	An)-tumor	immunosurveillance	and	Immunotherapy	
	
BACKGROUND	
	
Among	regula9on	mechanisms,	the	role	of	extracellular	vesicles,	such	as	the	exosomes,	released	by	cancer	cells	 in	tumor	microenvironment	appears	to	be	a	mechanism	used	by	tumor	cells	to	disseminate	bioinforma9on	in	
autocrine	and	paracrine	manner.	This	communica9on	can	be	achieved	by	direct	contact	or	over	long	distances	and	could	help	cancer	prolifera9on	and	metastases	and	to	alter	immune	cell	responses1,2.	These	endosome-derived	
vesicles	of	30–100	nm	are	formed	in	the	mul9vesicular	bodies	and	then	released	from	the	cell	into	the	extracellular	space.	They	carry	a	broad	range	of	cargo,	including	proteins,	noncoding	RNAs	(miRNAs,	lncRNAs…),	mRNAs,	and	
DNA	fragments,	to	target	cells.	Upon	entering	the	target	cell,	the	exosomes	induce	modula9on	of	cell	func9on	and	even	iden9ty	switch	(phenotypic	and	epigene9c).		
	
Mul9ple	miRNAs	have	been	described	to	play	key	roles	in	T	lymphocytes	development,	differen9a9on	and	func9on.	Upon	ac9va9on,	T	cells	undergo	global	gene	expression	remodeling	to	support	cell	growth,	prolifera9on,	and	
effector	func9ons.	All	changes	in	this	paQern	of	expression	could	have	consequences	on	T	cell	ac9va9on	and	response	to	melanoma.	
	
Although	specific	immune	responses	are	oTen	amplified	in	melanoma	pa9ents,	several	mechanisms	could	contribute	to	the	failure	of	T	cell	responses,	inducing	tumor	escape.	Tumor-derived	exosomes	are	major	par9cipants	of	
this	immune	evasion.	We	postulate	that	most	of	these	effects	are	carried	by	miRNAs	encapsulated	in	exosomes	that	could	influence	the	proper9es	of	recipient	cells	present	in	the	tumor	microenvironment.	
RESULTS	
miRNA	content	
Three	 human	 melanoma	 cell	 lines	 were	 established	 from	 surgical	 specimens	 obtained	 from	 primary	 or	
metasta9c	tumors	called	M113,	M117	and	M28.	We	analyzed	the	miRNA	content	of	melanoma	cell-derived	
exosomes	 and	 iden9fied	 216	 miRNAs	 enriched	 in	 exosome	 compare	 to	 donor	 melanoma	 cell	 lines.	 The	
miRNA	 content	was	 highly	 similar	 between	 exosomes	 (r2=0.98),	 independently	 of	 their	 donor	 cell	 origins	
(Figure	 1).	 Among	 these	 216	 miRNAs,	 some	 have	 been	 previously	 associated	 with	 metastasis	 or	
angiogenesis,	and	2	with	T	cell	response	(miR-122	and	miR-149).	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Immune	recipient	cells		
To	determine	whether	the	exosomes	and	their	cargo	could	be	taken	up	by	CD8+	T	cells,	we	u9lize	an	in	vitro	
experimental	model	where	exosomes	isolated	from	Melanoma	cell	lines	were	incubated	with	T	cells	during	5	
or	24	hours.	To	visualize	the	internaliza9on	of	the	vesicles	into	CD8+	T	cells	,	exosomes	were	stained	 	with	
PKH67.	The	 internaliza9on	of	exosomes	was	evidenced	by	a	green	fluorescent	punctuate	signal	 inside	 the	
cytoplasm	of	recipient	T	cells	(Figure	2A).		
	
The	transfer	content	was	confirmed	by	specific	qRT-PCR	for	two	enriched	miRNAs	in	exosomes:	miR-149	and	
miR-122.	We	observed	a	two-	to	six-fold	enrichment	of	these	miRNAs	in	the	exposed	T	cells	(Figure	2B).		
	
Exosome	and	immune	response	
We	next	inves9gated	whether	melanoma	exosomes	containing	miR-122	and	miR149	would	have	an	impact	
on	the	ac9vated	T	cells.	The	melanoma	exosomes	have	no	impact	on	T	cell	prolifera9on	or	death	(data	not	
shown).	We	showed	a	downregula9on	of	several	messenger	RNAs	coding	for	proteins	implicated	in	the	T	cell	
receptor	 signaling	 pathway	 (Kegg	 hsa04660,	 Figure	 3)	 aTer	 24h	 of	 co-culture.	We	 observed	 a	 decreasing	
expression	of	co-s9mulatory	molecule	CD3,	CD28	and	CD45,	and	several	cytokines	(interleukin-2	(IL-2),	IL-5,	
IL-10,	 IFNγ	and	GM-CSF).	 For	now,	using	ELISA	assays,	we	 replicated	 these	 results	by	 the	observa9on	of	a	
reduce	secre9on	of	IL-2	(p<0.05)	and	a	trend	to	a	reduced	secre9on	of	IFNγ	(not	significant)	by	the	CD8+	T	
cells	exposed	 to	melanoma	exosomes	 (Figure	4).	Since	miR-149	 targets	TNFα,	we	also	evaluated	 the	TNFα	
secre9on	 by	 T	 cells	 exposed	 or	 not	 to	 melanoma	 exosomes,	 and	 found	 a	 significant	 decrease	 of	 TNFα	
(p<0.05)	in	exposed	cells	(Figure	4).	
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Figure	1.	Hierarchical	clustering	of	miRNA	expression	from	exosomes	and	donor	cells.	The	color	scale	bar	(green-black-red)	
indicate	increasing	expression	levels.	On	the	leT,	correla9on	graph	across	exsomes	and	donor	cells	or	exosomes/exosomes.	
Figure	3.	Log2	fold	changes	of	gene	expression	level	mapped	onto	the	KEGG	pathway	module	«	T	cell	receptor	signaling	
pathway	».	Most	genes	in	this	pathway	showed	decreased	expression	in	CD8+	T	cells	exposed	to	melanoma	exosomes	(in	
green).	In	white,	non	tested	genes.	
METHODS	
Exosome	purifica7on	
Exosomes	 were	 recovered	 from	 the	 supernatant	 of	 melanoma	 cells	 cultured	 for	 24	 hours	 in	 depleted	
medium	 (i.e.	medium	 depleted	 from	 FCS-derived	 exosomes).	 Exosomes	 were	 purified	 using	 Exoquick	 TC	
(SBI).	 In	 each	 exosome	 prepara9on,	 the	 concentra9on	 of	 total	 proteins	 was	 quan9fied	 by	 BCA	
(Thermofisher).	
	
miRNA	assay	
Total	 RNA	 including	miRNA	was	 isolated	 from	melanoma	 cell	 lines	 and	 exosomes	 using	 the	miRNeasy	 kit	
(Qiagen).	 The	 miRNA	 expression	 profiles	 were	 analyzed	 by	 GeneChip	 miRNA	 4.0	 array	 (Affymetrix)	 and	
validated	by	RT-qPCR	using	Mys9Cq	microRNA	quan9ta9on	system	(Sigma).	
	
T	cell	assay	
Melanoma	exosomes	(4μg)	were	 incubated	with	2.105	CD8+	T	cells	 in	coated	with	an9-CD3	96-well	plated		
for	5	or	24	hours.	TNFα	and	IFNγ	secre9ons	were	measured	by	ELISA	kits	(Affymetrix).	
	
Confocal	microscopy	
T	 cells	 were	 incubated	 with	 exosomes	 as	 described	 in	 “T	 cell	 assay”.	 Cells	 were	 fixed	 in	 4%	
paraformaldehyde.	We	used	PKH67	and	WGA647	 to	 stain	 respec9vely	 the	exosomes	and	 the	 cytoplasmic	
membrane.	 Nuclei	 were	 counterstained	 with	 Hoechst.	 Cell	 observa9ons	 and	 images	 processing	 were	
performed	with	a	Nikon	A1	N-SIM	(MicroPicell	plaworm).	
	
T	cell	gene	expression	analysis	
Total	RNA	was	isolated	from	CD8+	T	cells	using	the	miRNeasy	kit	(Qiagen).	To	generate	sufficient	material,	
we	used	the	whole	transcriptome	amplifica9on	kit	(WTA2,	sigma).	The	final	cDNA	product	was	used		for	the	
RT2	Profiler	PCR	Array	“Human	T-cell	&	B-cell	ac9va9on”	using	Maxima	SybR	Green/ROX	qPCR	Master	Mix	
(Thermofisher).	
CONCLUSION	
Although	exosomes	have	been	studied	for	a	number	of	years,	the	biological	roles	of	exosomal	miRNAs	are	just	beginning	to	be	invesNgated3-6.		
Our	data	demonstrate	that	miRNA	are	released	from	melanoma	cells	in	exosomes	and	are	taken	up	by	recipient	CD8+	T	cells	and	subsequently	could	modulate	target	gene	expression.		
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Figure	4.	Cytokine	secre9on	by	CD8+	T	cells	24h	aTer	exposi9on	to	melanoma	exosomes.	For	each	plot,	n=3.	(1)	CD8+	T	cell	clone	1	against	melanoma	;	(2)	CD8+	T	cell	clone	2	against	melanoma	;	(3)	polyclonal	CD8+	T	cell	popula9on	
Figure	2.	
	A)	Confocal	microscopy	of	melanoma	
exosomes	(in	green)	internalized	in	a	
CD8+	T	cell.		
B)	RT-qPCR	of	miR-122	(in	black)	and	
-149	(in	grey)	in	CD8+	T	cells	exposed	
to	melanoma	exosomes.	0	
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